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Anti-smoking legislation has been associated with an improvement in health indicators. Since the
cadmium (Cd) body burden in the general population is markedly increased by smoke exposure, we
analyzed the impact of the more restrictive legislation that came into force in Spain in 2011 by measuring
Cd and cotinine in ﬁrst morning urine samples from 83 adults in Madrid (Spain) before (2010) and after
(2011) introduction of this law. Individual pair-wise comparisons showed a reduction of creatinine
corrected Cotinine and Cd levels for non-active smokers, i. e. those which urinary cotinine levels are
below 50 μg/L. After the application of the stricter law, cotinine levels in urine only decreased in non-
active smokers who self-reported not to be exposed to second-hand smoke. The reduction in second
hand smoke exposure was signiﬁcantly higher in weekends (Friday to Sunday) than in working days
(Monday to Thursday). The decrease in U-Cd was highly signiﬁcant in non-active smokers and, in general,
correlated with lower creatinine excretion. Therefore correction by creatinine could bias urinary Cd
results, at least for cotinine levels higher than 500 μg/L.
The biochemical/toxicological beneﬁts detected herein support the stricter application of anti-
smoking legislation and emphasize the need to raise the awareness of the population as regards
exposure at home.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Tobacco use contributes to respiratory, renal and cardiovascular
problems, increases the risk of cancer, and is considered to be the
single most signiﬁcant cause of preventable diseases, disability
and premature mortality in most developed countries (CDC, 2013).
The implementation of comprehensive national anti-smoking
legislation (banning smoking in indoor public spaces or in all
workplaces) has been associated with improvements in indoor airInc. This is an open access article u
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. López),quality and in a number of health outcomes in non-smoking
workers and the general population, including fewer respiratory
and sensory symptoms and improvements in lung function (Hahn,
2010; CDC, 2013). Moreover, such legislation has been associated
with reductions in the overall number of heart attacks and
asthma-related hospital admissions (Institute of Medicine, 2009;
Sims et al., 2013), and of preterm births (Kabir et al., 2009).
Spain became a party to the WHO Framework Convention on
Tobacco Control in 2005. The ﬁrst legislation governing smoking in
public places and tobacco advertising, promotion and sponsorship
(Law 28/2005) achieved a considerable reduction in exposure to
environmental tobacco smoke in the workplace and, to a lesser
extent, in bars and restaurants (Galán et al. 2007). In January 2011,
new legislation (Law 42/2010) substantially amended the previous
law by mandating an additional ban on smoking in indoor public
places and workplaces, and repealed provisions that permitted
designated smoking rooms, which had been used to continue to
allow smoking in most bars, restaurants and airports. According to
Spain's National Statistics Institute, in 2001 31.7% of the populationnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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the lowest for the past 25 years (INE, 2013).
Cigarette smoke contains more than 7000 chemical substances,
including nicotine, cotinine and toxic metals such as cadmium (Cd)
(CDC, 2013). Cotinine is also the major metabolite of nicotine, with
a longer half-life, and, as such, is frequently used to distinguish
smokers from non-smokers and in studies of passive smoking (O′
Connor et al., 1995). For the general population, cigarette smoking
may represent a major source of chronic exposure to Cd. The
amount of this metal absorbed upon smoking one pack of cigar-
ettes per day is about 1–3 μg/day (ATSDR, 2012). Smoking roughly
doubles the Cd body burden in comparison to not smoking, mainly
in the kidney, as reﬂected by urinary Cd (U-Cd) (ATSDR, 2012).
Furthermore, a very large fraction of Cd is released into side-
stream smoke, which is the main component of second-hand
smoke (SHS) (Wu et al. 1995). Passive smoking has been related to
increased Cd levels in blood (Shaham et al., 1996) and children's
hair (Razi et al., 2012), although other authors have found no such
association (Becker et al., 2007; McElroy et al., 2007; Richter et al.,
2009).
Both Cd and tobacco smoke are classiﬁed by the International
Agency for Research on Cancer as carcinogenic for humans, Group
1 (IARC, 2013). Long-term human exposure to Cd has been
associated with renal, cardiovascular, lung and bone diseases
(Järup and Akesson, 2009; ATSDR, 2012), reproductive, fetal-
growth and child-development problems (Satarug and Moore
2004; Kippler et al. 2012; Ciesielski et al. 2012) and other diseases
(Han et al., 2009; Satarug et al., 2010). Indeed, Cd may mediate the
effect of smoking on the development of tobacco-related lung
disease (Mannino et al., 2004; Lampe et al., 2008) and peripheral
artery disease (Navas-Acien et al., 2004).
In light of the above, it is important to establish whether a
stricter smoking ban has an impact on the reduction of cotinine
and Cd load in the general population. To this end, we have
evaluated whether urinary cotinine and Cd excretion in a group of
adults living in Madrid (Spain) was modiﬁed after application of
the above-mentioned law.2. Material and methods
2.1. Recruitment
During their annual medical check-up, workers from the
Instituto de Salud Carlos III (ISCIII) in Madrid (Spain) were asked
to participate in a biomonitoring study running from 2007 to 2011
(Castaño et al., 2012). Each year, participants were requested to
sign an informed consent, complete a self-administered question-
naire and provide a ﬁrst morning urine sample. The questionnaire
included lifestyle habits, such as smoking and smoke-exposure
patterns. Veriﬁcation of the subjects' smoking habits and body
mass index (BMI) was obtained from the occupational health
physician's report. Both the questionnaire and the study were
approved by the ISCIII's Prevention Service to comply with the
Declaration of Helsinki for human subject research (WMA, 2008).
A total of 83 non-occupationally exposed participants (59
women and 24 men) aged 25–62 years, whose urine samples
were collected in both 2010 and 2011 and had creatinine values of
between 0.3 and 3 g/L, were selected for inclusion in this study.
This cohort constitutes a very stable population with no great
variations in lifestyle habits and diet, as seen from the question-
naires and a preliminary comparison of the main dietary food
groups (vegetables, pasta, bread/cereals, legumes; data not
shown). Ferritin serum levels were relatively constant for each
participant in the study period and higher than 6.5 μg/L for
women and 16.6 μg/L for men.2.2. Chemical analysis
Urine samples were aliquoted and stored at 20 °C in poly-
propylene tubes prewashed with 10% HNO3 until analysis. Creati-
nine concentrations were determined for 1:40 dilutions using the
Jaffé alkaline picrate method (Spinreact Kit, Spain).
Urinary cotinine (U-cot) was ﬁrst determined by HPLC using a
Diode Array Detector (Bartolomé et al., 2014). Brieﬂy, 5 ml urine
plus 2-phenylimidazol, as internal standard, was extracted on a
solid phase using Oasis HLB cartridges (Waters, USA), evaporated
to dryness under nitrogen and reconstituted with mobile phase
solution (milli-Q water, acetonitrile). A 25 μL aliquot was injected
into an HPLC system (Agilent Technologies, 1200), with detection
at 259 nm (LOQ 15 μg/L).
For U-cot concentrations below 25 μg/L, the urine extract was
reconstituted with 50 μL toluene and a 2 μL aliquot was injected
into a single quadrupole, selected ion monitoring, electron impact
gas chromatography–mass spectrometer (Agilent Technologies
5975C), with an LOQ of 1 μg/L. The results are expressed as
creatinine-corrected cotinine (U-cotcr).
Urinary cadmium (U-Cd) analyzes were performed in the same
run, from October to December 2012, using a Dynamic Reaction
Cell (DRC)-ICP-MS (PerkinElmer ELAN DRC-e), as described by
Cañas et al. (2013). Brieﬂy, mixed urine samples were diluted 1:5
in 10% HNO3 containing 20 μg/L rhodium as internal standard
(Merck KgaA, Germany) and the DRC parameters were a ﬂow rate
of 1.7 mL/min oxygen (Air Liquide) and 0.7 Rpq. External calibra-
tion ranges were 0.025–10 μg/L (Cd standard, Perkin Elmer, USA)
and the limit of quantiﬁcation (LOQ) was 0.025 μg/L. As an internal
quality control check, the accuracy of the results was checked by
analysis of the certiﬁed reference material Clinchecks urine
(Recipe, Germany) analyzed every ten samples. The values ob-
tained (2.3370.19 μg/L, N¼17, and 1.8170.06 μg/L, N¼16) were
in good agreement with the certiﬁed values (1.94–2.90 μg/L and
1.71–2.57 μg/L, respectively).
During the measurements we participated in three Quebec
Multielement External Quality Assessment Schemes (QMEQAS) as
an external quality control. The values obtained (0.8470.06,
2.2970.07 and 14.0370.13 μg/L) were in good agreement with
the consensus values (1.0770.15, 2.5070.16 and 14.0670.90 μg/
L, respectively). The coefﬁcient of analytical variation for U-Cd was
10%.2.3. Statistical analysis
All analyzes were performed using PAWS Statistics 19 and
STATA 11. Urine levels below the LOQ were replaced with LOQ/
√2 (Hornung and Reed, 1990). Two groups were established for
active / passive smoking behavior, thus, in the active smokers
group were included those individuals with U-cot levels above or
equal 50 μg/L (SRNT, 2002). The urinary biomarker levels esti-
mated before and after introduction of the stricter anti-smoking
legislation, i.e. in 2010 and 2011, were compared using Wilcoxon
test for related samples. Comparisons between groups of different
U-cot level or SHSe in non-active smokers were performed using
Mann Whitney U-test for biomarker concentrations and a z-test
for proportions. Statistical signiﬁcance was established at po0.05.
The intra-class correlation coefﬁcient (ICC), i.e. the inter-parti-
cipant variance divided by the sum of inter- and intra-participant
variance, was used to compare the agreement between repeated
measurements of continuous variables. Additionally, Spearman's
or Pearson's correlations were used to estimate associations
between concentration measures and between the analytes
quantiﬁed.
Table 2
Levels of urinary cotinine and cadmium, both creatinine-corrected, in the two
groups stratiﬁed by cotinine levels in the two campaigns studied (2010 and 2011,
N¼83).
Group U-cotcr (μg/g) U-Cdcr (μg/g)
2010a 2011a pa %c 2010a 2011a pa %c
U-coto50lg/
L (N¼66)
Median 0.8 0.7 0.049 62 0.17 0.10 o0.001 76
p25 0.5 0.4 0.11 0.06
p75 1.2 1.0 0.29 0.22
U-cotZ50lg/
L (N¼17)
Median 839.8 865.7 NS 53 0.25 0.24 NS 76
p25 318.0 443.2 0.17 0.17
p75 1167.2 1262.2 0.43 0.38
pMW-testb o0.001 o0.001 NS 0.014
a Wilcoxon test for related samples comparing 2010 and 2011 individual values.
b Comparison between U-cot groups by Mann–Whitney test.
c Percentage of individuals who showed an analyte reduction. No signiﬁcant
difference between U-cot levels groups, by z-test.
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Table 1 outlines the age, gender distribution, BMI and smoking
habit (urinary cotinine groups) for the study population. No
statistically signiﬁcant differences in terms of either gender
composition (about 71% women and 29% men) or age were found
between U-cot groups (passive- and active-smokers). The BMI
values for the total population were higher at the end of the study.
There were no differences in BMI between U-cot groups.
Classiﬁcation based on urinary cotinine levels was the same in
both campaigns. Concerning self-reported information, the only
participant who claimed to have quit smoking between 2010 and
2011 was considered to continue smoking as the U-Cot value for
2011 was high (604 μg/L). Based on the questionnaire, one
participant declared to be a smoker although his U-cot level were
o30 μg/L, and other as non-smoker, but had U-cot levels
4100 μg/L. The number of self-reported cigarettes smoked per
day the week prior to sample collection did not decrease
signiﬁcantly (1372 vs.1172, n¼15) among both campaigns. No
subject smoked more than 20 cigarettes daily. Self-reporting
information on secondhand smoke exposure for any period of
the week was answered by 79 participants, 62 with U-coto50
μg/L.
Table 2 presents U-cotcr and U-Cdcr values in terms of U-cot
stratiﬁcation. In 2011, 60% of the population had lower U-cotcr
levels than in 2010 (62% and 53% in low and high U-cot groups,
respectively). Only the low U-cot group (non-active smokers)
showed a signiﬁcant variation in the pair-wise comparison for
the two sampling periods (po0.05).
Based on self-reported information, the decrease in U-cotcr
level in the group of non-active smokers (U-cot o50 ug/L) was
signiﬁcant only in those which were not exposed to SHS (p¼0.012,
Fig. 1a). The cotinine levels in 2011 was signiﬁcantly lower for
those not SHSe at weekends (p¼0.029), while no differed between
exposed or not at working days (from Mondays to Thursdays)
(Fig. 1b).
Approximately 1–8% of study participants had urinary cad-
mium levels (U-Cd) below the LOQ before and after introduction of
the anti-smoking legislation, respectively. The highest value (one
volunteer with almost 1 μg Cd/g creatinine) was obtained in 2010.
In general, a decrease in U-Cdcr was observed in 2011 when
compared to 2010 in 76% of participants. Cadmium in 2011 was
lowest for group with U-coto50 μg/L in comparison both with its
previous values (po0.001) and with the U-cotZ50 μg/L groupTable 1
Descriptive parameters of the study population in the two sampling campaigns 2010 and
stratiﬁed by cotinine level in urine considering active smokers those with cotinine leve
n (%)a Age (years) 2010b BM
n
All 83 (100) 44.579.4 (44.0) 80
Women 59 (71.1)
Men 24 (28.9)
U-Coto50 μg/L 66 (79.5) 44.979.0 (44.5) 64
Women 47 (71.2)
Men 19 (28.8)
U-CotZ50lg/L 17 (20.5) 42.9710.7 (39.0) 16
Women 12 (70.6)
Men 5 (29.4)
pMW-testd NS
a Arithmetic mean7SD (median). BMI, Body Mass Index.
b Gender proportions between U-cot groups, z-test: NS.
c Wilcoxon test for related samples, comparing 2010 and 2011 individual values.
d Mann Whitney U-test for independent samples, comparing U-Cot groups.(po0.05) after introduction of stricter anti-smoking legislation
(Table 2). No difference in U-Cdcr were found in relation to SHSe.
Measures of correlation, variation and reliability for all analytes
can be found in Table 3 (a,b and c). The proportions of total outcome
variance due to inter-individual variation, i.e. including external
factors, were estimated as the intra-class correlation coefﬁcient
(Table 3a). For U-Cd, the inter-variation between the two measures
was 55% expressed in volume and 72% as creatinine-corrected
levels, Creatinine per se showed less inter-variation (45%) than
Cd, and U-cot variation was mainly external (93–96%), as expected.
In Table 3b, Spearman's coefﬁcient was 0.8 for cadmium
(U-Cdcr) and 0.4–0.5 for creatinine between 2010 and 2011
(po0.001), irrespective of U-cot group. The correlation between
creatinine-corrected and -uncorrected Cd levels was slightly high-
er after the law came into force, while U-cot correlated well
between both years and between its volume and creatinine-
corrected values. However, U-cot Z50 μg/L group always showed
the lowest correlation value between creatinine-corrected and
-uncorrected values for U-Cd and U-cot.2011, before and after smoking-free law entered into force respectively. Groups are
ls above or equal 50 μg/L. Volunteers were recruited in Madrid Region, Spain.
I (kg/cm2)b
2010 2011 pc
24.874.9 (24.1) 25.374.7 (24.1) o0.001
24.774.1 (24.1) 25.074.0 (24.1) 0.001
25.177.4 (23.6) 26.277.0 (24.1) 0.010
NS NS
Fig. 1. Comparison of creatinine corrected cotinine levels (U-cotcr) in the group of
non-active smokers ( U-coto50 μg/L) according to self-reported information on
Second Hand Smoke exposure (SHSe). Medians and CI 75% (N¼62). (A) SHSe at any
period of the week: U-cotcr before (2010) and after (2011) application of stricter
antismoking ban in Spain were compared by Wilcoxon test for related samples,
*p¼0.012. (B) SHSe at different periods of the week for 2011 samples. Mann–
Whitney U-test: *p¼0.029; **p¼0.009.
Table 3a
Reproducibility and correlation measures for the sampling campaigns before and
after the anti-smoking legislation came into force. Intra-class correlation coefﬁ-
cient, biomarker Ln-transformed (N¼83, po0.001).
ICC (95%CI)
lg/L lg/g creatinine
Cadmium (U-Cd) 0.55 (0.36–0.70) 0.72 (0.39-0.85)
Cotinine (U-cot) 0.96 (0.93–0.97) 0.93 (0.90-0.96)
Creatinine 0.45 (0.26–0.60) —
Table 3b
Reproducibility and correlation measures for the sampling campaigns before and
after the anti-smoking legislation came into force. Spearman’s coefﬁcient between
concentration measures of the same analyte (N¼83).
2010 vs 2011 vs lg/L
2010 2011
U-Cdcr (lg/g creatinine) All 0.82nnn 0.70nnn 0.83nnn
U-coto50mg/L 0.78nnn 0.70nnn 0.83nnn
U-cotZ50mg/L 0.77nn 0.48 0.63nn
Creatinine (lg/L) All1 0.43nnn — —
U-coto50mg/L 0.53n — —
U-cotZ50mg/L 0.53n — —
U-cotcr (lg/g creatinine) All1 0.65nnn 0.79nnn 0.73nnn
U-cotZ50mg/L 0.55n 0.57n 0.56n
n po0.05
nn po 0.01
nnn po0.001
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same good correlation with the self-reported number of cigarettes
smoked per day in 2010, whereas no such associations were found
in 2011 for creatinine-corrected analytes (Table 3c). The good
correlation obtained for active smokers in 2010 between U-Cd and
U-cot, creatinine-corrected or not, decreased after the law came
into force.A residual negative correlation between creatinine and both
U-Cdcr and U-cotcr was obtained upon creatinine correction,
thereby suggesting an over-adjustment and a residual inﬂuence
of diuresis on Cd levels. In 2011, the coefﬁcient for U-Cdcr
decreased to non-signiﬁcant values when U-coto50 μg/L were
included, i.e. Spearmans' rho for this group changed from 0.32
(p¼0.01) in 2010 to 0.14 in 2011, while the correlation between
U-Cd and U-Cdcr was higher (Table 3b). A linear ﬁt of volume and
creatinine-corrected indicators of cadmium and creatinine con-
centration with respect to cotinine (Fig. 2) showed that creatinine
and both U-Cd concentration expressions decrease as U-cot
decreases. U-Cd and U-Cdcr tend to converge on the same value
(about 0.2) for U-cot o500 μg/L, i.e. the creatinine value appears
to be unitary (1 g/L) at these metal and cotinine concentrations.4. Discussion
Urinary cadmium levels are assumed to be proportional to
kidney Cd stores and to reﬂect overall body burden as long as
kidney function remains intact (EFSA, 2009; Järup and Åkesson,
2009). The median U-Cd levels found in the urine of our volun-
teers are far lower than 1 μgCd/g creatinine, the European Food
Safety Authority threshold value for protection against kidney
damage, thereby suggesting the lack of an important exposure
source of this metal (EFSA, 2009). However, a reduction in Cd
exposure is still relevant as adverse effects have been reported for
the kidney and on bone and neurodevelopmental deﬁcits at U-Cdcr
concentrations as low as 1 μgCd/g creatinine (Järup and Åkesson,
2009, Ciesielski et al., 2012). Even at lower concentrations
(o0.50 μg/g creatinine) Cd has been reported to be associated
with hypertension and cardiovascular disease (Tellez–Plaza et al.,
2012b), breast cancer incidence (McElroy et al., 2006) and mor-
tality (Menke et al., 2009; Adams et al., 2012).
Table 3c
Reproducibility and correlation measures for the sampling campaigns before and after the anti-smoking legislation came into force. Spearman’s correlation coefﬁcient
between different analytes (N¼83).
Cigarettes/day U-cot (lg/L) U-cotcr (lg/g creatinine) Creatinine (g/l)
2010 2011 2010 2011 2010 2011 2010 2011
U-Cd (lg/L)
All 0.20 0.27n 0.40nnn 0.41nnn
U-cot Z50mg/L 0.65nn 0.63n 0.80nnn 0.29 0.47 0.28
U-Cdcr (lg/g creatinine)
All 0.27n 0.27n 0.32nn 0.14
U-cot Z50mg/L 0.57n 0.49 0.68n 0.45 0.46 0.50n
U-cot (lg/L)
All 0.14 0.06
U-cot Z50mg/L 0.75nn 0.70nn 0.42 0.02
U-cotcr (lg/g creatinine)
All 0.41nnn 0.55nnn
U-cot Z50mg/L 0.57n 0.34 0.43 0.77nnn
nn po 0.01
n po0.05
nnn po0.001
Fig. 2. Linear ﬁt of volume (μg/L) and creatinine-corrected (μg/g) indicators of
cadmium and creatinine with respect to cotinine. Creatinine levels decrease and
both Cd values tend to converge as cotinine decreases to below o500 μg/L. Pearson
correlation coefﬁcient (r) and signiﬁcance level (p) were given for creatinine
(r¼0.17, p¼0.025) and uncorrected and creatinine-corrected Cd (r¼0.36,
po0.001 and r¼0.22, p¼0.005, respectively).
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decreased signiﬁcantly in passive smokers, i.e. those with
U-coto50 μg/L, especially if these subjects declared not to be
SHSe (p¼0,012). In general, cotinine decrease mirrored in the
smoking habit countrywide, since the number of cigarettes sold in
2011 decreased by 16.7% with respect to 2010 and the smoke
exposure at work and in indoor public places and transport
reduced dramatically respect to 2006 (INE, 2013).
Spanish indoor workplaces, bars and restaurants that became
smoke-free experienced improved air quality, as measured by
nicotine in air (Nebot et al., 2009) or PM2.5 concentration
(Córdoba et al., 2013). Law 42/2010 was expected to reduce smoke
exposure in public places mainly at weekends, since exposure
during the week (Monday to Thursday) is either home or tends to
be more work-related, and the last one was regulated previously
(Law 28/2005). Accordingly, in 2011 we found a statistical sig-
niﬁcant difference in U-cotcr levels between those SHEe atweekends and not for those SHEe from Monday to Thursday. Thus,
after implementation of the latest smoking ban legislation in 2010,
home happened to be the most common site for smoke exposure
(17.8%) (INE, 2013). Callinan et al.'s (2010) meta-analysis revealed
that, despite a greater reduction in SHSe in bar and restaurant
workers upon implementation of a legislative ban, the prevalence
or duration of self-reported exposure at home did not change. As
such, there continues to be a need to reduce smoking in enclosed
areas and/or to promote smoke ventilation. Better informed
smokers are more likely to have smoke-free homes and to abstain
from smoking in a room with children (Evans et al., 2012).
Cadmium levels decreased signiﬁcantly too in the group with
U-coto50 μg/L but showed less variations and more marked
reduction than urinary cotinine levels (Table 2). Wu et al. (1995)
found that airborne Cd was the most promising environmental
marker for tobacco smoke as it has a similar content and emission
factor for different brands of cigarettes and is found at elevated
levels in ﬁne respirable particles. These particles can penetrate the
deepest parts of the human lung and affect the cadmium body
burden.
The decrease in cadmium levels (U-Cdcr) found in 76% of our
participants indicates a positive change between both years. Our
results comparing individual levels showed this effect just a year
after implementation of the stricter anti-smoking legislation,
probably favoured by the low concentration detected and the
stability of our population. However, the more signiﬁcant Cd than
cotinine reduction might also be favoured by the less average air
Cd concentration detected in Madrid (0.6 ng/m3 in 2010 and 0.4
ng/m3 in 2011) (Madrid, 2011) and by the BMI increment (Riederer
et al., 2013).The observed trends should be revaluated in the future
years to conﬁrm these ﬁndings in a long term. NHANES U-Cd
reduction concentrations have been reported over a 20-year
period (1988–2008) by Tellez-Plaza (2012a) who highlighted the
decrease in smoking rates and changes in tobacco smoke
exposure.
The intra-class correlation coefﬁcient (ICC) for U-Cd values was
higher than the estimates of less than 50% found by Gunier et al.
(2013) and Karmaus et al. (2008). Although this might mirror
changes in smoke exposure, the non-randomness of our popula-
tion may lead to an overestimation of the inter-person variance
and underestimate the intra-person variance, thereby resulting in
a higher ICC. For the group with levels of U-cotZ50 μg/L
J.E. Sánchez-Rodríguez et al. / Environmental Research 136 (2015) 227–233232(Table 3c), we found a higher correlation between both biomar-
kers, before introduction of the new law (0.68, po0.05 vs 0.45,
NS), thus suggesting that smoke was a more important source of
Cd in 2010 than in 2011. This association was low for the
population as a whole (0.3, po0.05) and persisted in time, as
would be expected if tobacco is not the main Cd source for the
general population, particularly non-smokers (ATSDR, 2012).
Nevertheless, the reduction in Cd urine concentration over the
year suggests that the change was registered at both an inter- and
intra-individual level.
In the data considered here, U-Cdcr values obtained before
implementation of the stricter anti-smoking legislation were
found to be negatively correlated to creatinine, thus indicating
an over-adjustment and a residual inﬂuence of diuresis on Cd
levels, in agreement with Chaumont et al. (2013). This association,
considering all participants in our study, was not signiﬁcant after
introduction of the legislation, whereas the correlation between
U-Cd and U-Cdcr was higher. It was remarkable that both Cd
indicators tend to converge on the same value at low U-cot levels,
i.e. the creatinine value tends to be unitary. It seems possible that a
global reduction in environmental smoke or nicotine exposure
might favor this effect, and the physiological response to these
changes may form part of the “unidentiﬁed time-related factors”
responsible for the unexplained Cd decreases mentioned by
Riederer et al. (2013).
Smoke exposure, which can be represented by U-cot, has been
associated with altered kidney structure and function (Wong et al.,
1992; Orth, 2002; Dülger et al., 2011; Budisavljevic and Ploth
2012). On the other hand, renal creatinine clearance is largely a
function of glomerular ﬁltration and some tubular secretion
(Jatlow et al., 2003) and nicotine′s antidiuretic effect (Miller and
Moses, 1976) or glomerular hyperﬁltration (Orth, 2002) might
mediate the higher urinary creatinine levels found in active
smokers by Dülger et al. (2011) and the slight creatinine increment
associated with cotinine observed in this study (r¼0.17, p¼0.025).
As such, creatinine-corrected cadmium (U-Cdcr) values are likely
to underestimate body Cd burden for smokers with respect to the
uncorrected U-Cd indicator and the lost relationship with cigar-
ettes smoked.
In addition, if creatinine, Cd or diuresis in general were altered
by smoke components, the U-Cd values might not reﬂect either
kidney or body burden or the same proportion of Cd burden
between smokers and non-smokers. Thus, Chaumont et al. (2013)
have reported an unexpectedly low increase in U-Cd for smokers
despite their continued higher exposure. As such, changes to renal
function that may result from smoking, which was long regarded
as merely an additional Cd source, should also be taken into
consideration. On the other hand, Cd alone could alter the results
as it might reduce cotinine clearance and induce the p-450 hepatic
metabolizing enzyme that participates in the conversion of nico-
tine to cotinine (Satarug et al., 2004a).
Some limitations should be taken into account for the present
study alongside other sources of variability and bias that could not
be accounted for. One of these is that the limited sample sizes for
certain population groups might have resulted in imprecise
assessments. Another one are the imprecision of a self-administer
questionnaire which ﬁnding of questions not answered which
prevent some comparisons or deeper analysis. Dietary Cd intake or
other sources of exposure were not expected to change over the
period considered as the population studied comprised adult non-
occupationally exposed workers (civil servants), who are relatively
homogeneous in terms of age, ethnicity and education and with a
lifestyle which tends to be stable.
To the best of our knowledge, this study is the ﬁrst to evaluate
the impact of smoke-free legislation on the U-cot and U-Cd values
for the same subjects. One year post-implementation, we foundindicators of a reduction in smoke exposure in non-active smokers
and a decrease in the body burden of Cd even at the low levels
registered. Although variations of 20% in U-Cdcr have been
described in overnight samples of urine (Akerstrom et al., 2014),
the most striking ﬁnding for our population is that the Cd values
decreased in 2011 with respect to those obtained in 2010 for 76%
of participants, thus prompting us to search for intra-individual
comparisons. This Cd decrease includes the analytical variability
(around 10%) and uncontrolled media changes, but our ﬁndings
nevertheless suggest the direction that future, conﬁrmatory stu-
dies should take. Although the follow-up (longitudinal) study for
several times or years after introduction of the legislation will
provide higher evidences, these results highlight the short-term
effectiveness of such measures on health, with likely long-term
outcomes including a lower prevalence of renal disease and its
associated cardiovascular morbidity. The perceived health impact
of smoke-related policies might renew interest in, and reinforce,
such policies and may also lead to the promotion and/or modiﬁca-
tion of new policies, such as campaigns to avoid SHSe or ventilate
smoking areas in the home.5. Conclusions
The stricter anti-smoking legislation was accompanied by a
decrease in cotinine (U-cotcr) in non-active smokers, which is
indicative of lower second hand smoke exposure. U-Cdcr, as a
biomarker of metal exposure, shows a healthy reduction in the
body burden for the same passive smokers studied. Home-based
smoke exposure continues to be a concern, thus highlighting the
need to invest in public awareness campaigns to endorse private
decisions.
Creatinine-corrected cadmium (U-Cdcr) values are likely to
underestimate body Cd burden at least for cotinine values above
500 μg/L, when compared to the uncorrected U-Cd indicator.Funding sources
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